Dan Howard is an accomplished professional in the field of clinical pharmacology, currently serving as the Head of Clinical Pharmacology and Pharmacometrics at Insmed Incorporated since June 2025. Prior to this role, Dan Howard was a consultant at Dan Howard Drug Development Consulting, LLC from January 2021 to June 2025. Dan Howard held significant positions at Novartis from June 2005 to June 2020, including Senior Vice President and Global Head of Pharmacokinetics Sciences and Site Head for the East Hanover NIBR. Earlier in Dan Howard's career, various leadership roles were held at Quintiles, including Vice President of Oncology Clinical Pharmacology and Vice President of Global PK/PD. Dan Howard's educational background includes studies at the University of Missouri-Kansas City.
This person is not in any teams
This person is not in any offices